21-Jan-2026 6:17 AM CST - Investing Snacks Revvity Q4 Results Top Estimates, Strong 2026 Outlook Revvity Q4 results exceeded expectations, driving a 6% stock gain. The life sciences company also issued an upbeat 2026 forecast with strong organic growth and EPS projections.
14-Jan-2026 4:08 AM CST - Benzinga Revvity Stock Gains On Solid Early Q4 Results, Upbeat Outlook (NYSE: RVTY) stock rose Tuesday after the life sciences and diagnostics company released preliminary expectations for the fourth quarter and fiscal year 2025. The positive movement comes despite broader market pressure,
12-Jan-2026 3:15 PM CST - Business Wire Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call. To access the call, a live audio webcast will be available on the Inves
18-Dec-2025 7:00 AM CST - Business Wire Revvity to Present at J.P. Morgan Healthcare Conference Revvity, Inc. (NYSE: RVTY) will present at the 44th annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT. President and Chief Executive Officer Prahlad Singh will provide an update on the Company and its strategic priorities. To access the presentation, a live audio webcast will be available on the Events section of the Companys website. A replay of the presentation will be posted on the Revvity Investor Relations website after
28-Oct-2025 8:32 AM CST - Benzinga Revvity Analysts Increase Their Forecasts After Q3 Earnings Revvity, Inc. (NYSE: RVTY) announced mixed third-quarter 2025 financial results on Monday. Despite adjusted EPS from continuing operations of $1.18, which beat the analyst estimate of $1.14, total revenue of $698.949 million missed the consensus estimate of $700.457 million.
28-Oct-2025 7:00 AM CST - Business Wire Revvity to Present at Upcoming Investor Conferences Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: UBS Global Healthcare Conference 2025 Monday, November 10, 2025 8:00 a.m. ET - Max Krakowiak, senior vice president and chief financial officer Jefferies 2025 London Healthcare Conference Tuesday, November 18, 2025 2:00 p.m. GMT Max Krakowiak Citi's 2025 Global Healthcare Conference Tuesday, December 2, 2025 9:00 a.m. ET Prahlad Singh, president and chief execu
27-Oct-2025 5:00 AM CST - Business Wire Revvity Announces Financial Results for the Third Quarter of 2025 Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended September 28, 2025. The Company reported GAAP earnings per share of $0.40, as compared to $0.77 in the same period a year ago. Revenue for the quarter was $699 million, as compared to $684 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $82 million, as compared to $98 million for the same period a year ago. GAAP ope
23-Oct-2025 3:54 PM CST - Seeking Alpha Revvity declares $0.07 dividend Revvity (NYSE:RVTY) declares $0.07/share quarterly dividend, in line with previous. Forward yield 0.29% Payable Feb. 6; for shareholders of record Jan. 16; ex-div Jan. 16. See RVTY Dividend Scorecard,
23-Oct-2025 3:05 PM CST - Business Wire Revvity Board Declares Quarterly Dividend The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 6, 2026 to all shareholders of record at the close of business on January 16, 2026. About Revvity At Revvity, impossible is inspiration, and cant be done is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows fro
Latest RVTY Trades by Congress Members
12-SEP-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
21-Jan-2026 6:17 AM CST - Investing Snacks Revvity Q4 Results Top Estimates, Strong 2026 Outlook Revvity Q4 results exceeded expectations, driving a 6% stock gain. The life sciences company also issued an upbeat 2026 forecast with strong organic growth and EPS projections.
14-Jan-2026 4:08 AM CST - Benzinga Revvity Stock Gains On Solid Early Q4 Results, Upbeat Outlook (NYSE: RVTY) stock rose Tuesday after the life sciences and diagnostics company released preliminary expectations for the fourth quarter and fiscal year 2025. The positive movement comes despite broader market pressure,
12-Jan-2026 3:15 PM CST - Business Wire Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call. To access the call, a live audio webcast will be available on the Inves
18-Dec-2025 7:00 AM CST - Business Wire Revvity to Present at J.P. Morgan Healthcare Conference Revvity, Inc. (NYSE: RVTY) will present at the 44th annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT. President and Chief Executive Officer Prahlad Singh will provide an update on the Company and its strategic priorities. To access the presentation, a live audio webcast will be available on the Events section of the Companys website. A replay of the presentation will be posted on the Revvity Investor Relations website after
28-Oct-2025 8:32 AM CST - Benzinga Revvity Analysts Increase Their Forecasts After Q3 Earnings Revvity, Inc. (NYSE: RVTY) announced mixed third-quarter 2025 financial results on Monday. Despite adjusted EPS from continuing operations of $1.18, which beat the analyst estimate of $1.14, total revenue of $698.949 million missed the consensus estimate of $700.457 million.
28-Oct-2025 7:00 AM CST - Business Wire Revvity to Present at Upcoming Investor Conferences Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: UBS Global Healthcare Conference 2025 Monday, November 10, 2025 8:00 a.m. ET - Max Krakowiak, senior vice president and chief financial officer Jefferies 2025 London Healthcare Conference Tuesday, November 18, 2025 2:00 p.m. GMT Max Krakowiak Citi's 2025 Global Healthcare Conference Tuesday, December 2, 2025 9:00 a.m. ET Prahlad Singh, president and chief execu
27-Oct-2025 5:00 AM CST - Business Wire Revvity Announces Financial Results for the Third Quarter of 2025 Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended September 28, 2025. The Company reported GAAP earnings per share of $0.40, as compared to $0.77 in the same period a year ago. Revenue for the quarter was $699 million, as compared to $684 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $82 million, as compared to $98 million for the same period a year ago. GAAP ope
23-Oct-2025 3:54 PM CST - Seeking Alpha Revvity declares $0.07 dividend Revvity (NYSE:RVTY) declares $0.07/share quarterly dividend, in line with previous. Forward yield 0.29% Payable Feb. 6; for shareholders of record Jan. 16; ex-div Jan. 16. See RVTY Dividend Scorecard,
23-Oct-2025 3:05 PM CST - Business Wire Revvity Board Declares Quarterly Dividend The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 6, 2026 to all shareholders of record at the close of business on January 16, 2026. About Revvity At Revvity, impossible is inspiration, and cant be done is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows fro
